Kathy B. Baumgartner

Kathy B. Baumgartner

Auto-generated profile, based on publicly available information

Kathy B. Baumgartner

University of Louisville

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2008 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
KMKathleen A. Meeske
Kathleen A. Meeske
JSJane Sullivan-Halley
Jane Sullivan-Halley
ASAshley Wilder Smith
Ashley Wilder Smith
AMAnne McTiernan
Anne McTiernan
KBKathy B. Baumgartner
Kathy B. Baumgartner
LBLeslie Bernstein
Leslie Bernstein

4 May 2022 in European Journal of Cancer
Verified
Journal Article
Open access
ESElena Shagisultanova
Elena Shagisultanova
DGDexiang Gao
Dexiang Gao
ECEryn Callihan
Eryn Callihan
HPHannah J. Parris
Hannah J. Parris
BRBetsy Risendal
Betsy Risendal
VBVirginia F. Borges
Virginia F. Borges
Women diagnosed with breast cancer prior to age 45 years (<45y) and within the first 5 years postpartum (postpartum breast cancer, PPBC) have the greatest risk for distal metastatic recurrence. Pooling data from the Colorado Young Women Breast Cancer cohort and the Breast Cancer Health Disparities Study (N=2519 cases), we examined the association of parity, age, and clinical factors with overall survival (OS) of breast cancer over 15 years of follow-up. Women with PPBC diagnosed at <45y had the lowest OS (p<0.0001), while OS of nulliparous cases diagnosed at <45y did not differ from OS of cases diagnosed 45–65y regardless of parity status. After adjustment for study site, race/ethnicity, clinical stage, year of diagnosis, and stratification for estrogen receptor status, PPBC remained an independent factor associated with poor OS. Among cases diagnosed at <45y, nulliparous cases had 1.6 times better OS (hazard ratio (HR)=0.61, 95%CI 0.42–0.87) compared to those with PPBC, with a more pronounced survival difference among stage I breast cancers (HR=0.30, 95%CI 0.11–0.79). Among very young women diagnosed at age ≤35y, nulliparous cases had 2.3 times better OS (HR=0.44, 95%CI 0.23–0.84) compared to PPBC. Our results suggest that postpartum status is the main driver of poor prognosis in young women with breast cancer, with the strongest association in patients diagnosed at age ≤35y and in those with stage I disease.

26 April 2016 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
ACAvonne E. Connor
Avonne E. Connor
KVKala Visvanathan
Kala Visvanathan
KBKathy B. Baumgartner
Kathy B. Baumgartner
RBRichard N. Baumgartner
Richard N. Baumgartner
SBStephanie D. Boone
Stephanie D. Boone
MSMartha L. Slattery
Martha L. Slattery

1 October 2001 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
RLRui Li
Rui Li
FGFrank D. Gilliland
Frank D. Gilliland
KBKathy B. Baumgartner
Kathy B. Baumgartner
JSJonathan Samet
Jonathan Samet

2 June 2017 in Communications in Statistics - Simulation and Computation
Verified
Journal Article
Closed access
ACA. C. Cambon
A. C. Cambon
KBK. B. Baumgartner
K. B. Baumgartner
GBGuy Brock
Guy Brock
NCN. G. F. Cooper
N. G. F. Cooper
DWD. Wu
D. Wu
SRShesh Nath Rai
Shesh Nath Rai
Traditional phase III clinical trials are powered to detect an overall treatment effect. However, it has increasingly been shown that many treatments are effective only for a subset of a population. The adaptive signature design uses genomic/proteomic information to prospectively predict a subset of patients more sensitive to treatment. Tests for overall treatment effect and for treatment effect in the predicted subset are conducted. In this work properties of the adaptive signature design are investigated through simulation. It was found that models which excluded expression main effect terms had higher empirical power than models which included them.

1 September 2001 in Journal of the American Dietetic Association
Verified
Journal Article
Closed access
RWR.S. Wold
R.S. Wold
WHW.C. Hunt
W.C. Hunt
KBK.B. Baumgartner
K.B. Baumgartner
DCD. Crumley
D. Crumley
RBR.N. Baumgartner
R.N. Baumgartner
RBR. Ballard-Barbash
R. Ballard-Barbash